Chapter/Section Purchase

Table of Contents
1 Market Overview
1.1 Neurological Biomarkers Introduction
1.2 Market Analysis by Type
1.2.1 Proteomics
1.2.2 Genomics
1.2.3 Imaging
1.2.4 Bioinformatics
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Diagnostics
1.3.2 Drug Discovery
1.3.3 Personalized Medicine
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Business Overview
2.1.1.1 Thermo Fisher Neurological Biomarkers Description
2.1.1.2 Thermo Fisher Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.1.2 Thermo Fisher Neurological Biomarkers Product Introduction
2.1.2.1 Production Bases, Sales Regions and Major Competitors
2.1.2.2 Thermo Fisher Neurological Biomarkers Product Introduction
2.1.3 Thermo Fisher Neurological Biomarkers Sales, Revenue and Market Share
2.1.3.1 Thermo Fisher Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.1.3.2 Thermo Fisher Neurological Biomarkers Market Share in Global in 2020
2.2 Merck
2.2.1 Business Overview
2.2.1.1 Merck Neurological Biomarkers Description
2.2.1.2 Merck Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.2.2 Thermo Fisher Neurological Biomarkers Product Introduction
2.2.2.1 Production Bases, Sales Regions and Major Competitors
2.2.2.2 Merck Neurological Biomarkers Product Introduction
2.2.3 Merck Neurological Biomarkers Sales, Revenue and Market Share
2.2.3.1 Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.2.3.2 Merck Neurological Biomarkers Market Share in Global in 2020
2.3 Bio-Rad Laboratories
2.3.1 Business Overview
2.3.1.1 Bio-Rad Laboratories Neurological Biomarkers Description
2.3.1.2 Bio-Rad Laboratories Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.3.2 Bio-Rad Laboratories Neurological Biomarkers Product Introduction
2.3.2.1 Production Bases, Sales Regions and Major Competitors
2.3.2.2 Bio-Rad Laboratories Neurological Biomarkers Product Introduction
2.3.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Market Share
2.3.3.1 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.3.3.2 Bio-Rad Laboratories Neurological Biomarkers Market Share in Global in 2020
2.4 Roche
2.4.1 Business Overview
2.4.1.1 Roche Neurological Biomarkers Description
2.4.1.2 Roche Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.4.2 Roche Neurological Biomarkers Product Introduction
2.4.2.1 Production Bases, Sales Regions and Major Competitors
2.4.2.2 Roche Neurological Biomarkers Product Introduction
2.4.3 Roche Neurological Biomarkers Sales, Revenue and Market Share
2.4.3.1 Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.4.3.2 Roche Neurological Biomarkers Market Share in Global in 2020
2.5 QIAGEN
2.5.1 Business Overview
2.5.1.1 QIAGEN Neurological Biomarkers Description
2.5.1.2 QIAGEN Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.5.2 QIAGEN Neurological Biomarkers Product Introduction
2.5.2.1 Production Bases, Sales Regions and Major Competitors
2.5.2.2 QIAGEN Neurological Biomarkers Product Introduction
2.5.3 QIAGEN Neurological Biomarkers Sales, Revenue and Market Share
2.5.3.1 QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.5.3.2 QIAGEN Neurological Biomarkers Market Share in Global in 2020
2.6 Athena Diagnostics
2.6.1 Business Overview
2.6.1.1 Athena Diagnostics Neurological Biomarkers Description
2.6.1.2 Athena Diagnostics Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.6.2 Athena Diagnostics Neurological Biomarkers Product Introduction
2.6.2.1 Production Bases, Sales Regions and Major Competitors
2.6.2.2 Athena Diagnostics Neurological Biomarkers Product Introduction
2.6.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue and Market Share
2.6.3.1 Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.6.3.2 Athena Diagnostics Neurological Biomarkers Market Share in Global in 2020
2.7 Myriad RBM
2.7.1 Business Overview
2.7.1.1 Myriad RBM Neurological Biomarkers Description
2.7.1.2 Myriad RBM Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.7.2 Myriad RBM Neurological Biomarkers Product Introduction
2.7.2.1 Production Bases, Sales Regions and Major Competitors
2.7.2.2 Myriad RBM Neurological Biomarkers Product Introduction
2.7.3 Myriad RBM Neurological Biomarkers Sales, Revenue and Market Share
2.7.3.1 Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.7.3.2 Myriad RBM Neurological Biomarkers Market Share in Global in 2020
2.8 Cisbio Bioassays
2.8.1 Business Overview
2.8.1.1 Cisbio Bioassays Neurological Biomarkers Description
2.8.1.2 Cisbio Bioassays Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.8.2 Cisbio Bioassays Neurological Biomarkers Product Introduction
2.8.2.1 Production Bases, Sales Regions and Major Competitors
2.8.2.2 Cisbio Bioassays Neurological Biomarkers Product Introduction
2.8.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Market Share
2.8.3.1 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.8.3.2 Cisbio Bioassays Neurological Biomarkers Market Share in Global in 2020
2.9 Wuxi APP
2.9.1 Business Overview
2.9.1.1 Wuxi APP Neurological Biomarkers Description
2.9.1.2 Wuxi APP Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.9.2 Wuxi APP Neurological Biomarkers Product Introduction
2.9.2.1 Production Bases, Sales Regions and Major Competitors
2.9.2.2 Wuxi APP Neurological Biomarkers Product Introduction
2.9.3 Wuxi APP Neurological Biomarkers Sales, Revenue and Market Share
2.9.3.1 Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.9.3.2 Wuxi APP Neurological Biomarkers Market Share in Global in 2020
2.10 BGI
2.10.1 Business Overview
2.10.1.1 BGI Neurological Biomarkers Description
2.10.1.2 BGI Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.10.2 BGI Neurological Biomarkers Product Introduction
2.10.2.1 Production Bases, Sales Regions and Major Competitors
2.10.2.2 BGI Neurological Biomarkers Product Introduction
2.10.3 BGI Neurological Biomarkers Sales, Revenue and Market Share
2.10.3.1 BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.10.3.2 BGI Neurological Biomarkers Market Share in Global in 2020
2.11 Aepodia
2.11.1 Business Overview
2.11.1.1 Aepodia Neurological Biomarkers Description
2.11.1.2 Aepodia Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.11.2 Aepodia Neurological Biomarkers Product Introduction
2.11.2.1 Production Bases, Sales Regions and Major Competitors
2.11.2.2 Aepodia Neurological Biomarkers Product Introduction
2.11.3 Aepodia Neurological Biomarkers Sales, Revenue and Market Share
2.11.3.1 Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.11.3.2 Aepodia Neurological Biomarkers Market Share in Global in 2020
2.12 Genewiz
2.12.1 Business Overview
2.12.1.1 Genewiz Neurological Biomarkers Description
2.12.1.2 Genewiz Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.12.2 Genewiz Neurological Biomarkers Product Introduction
2.12.2.1 Production Bases, Sales Regions and Major Competitors
2.12.2.2 Genewiz Neurological Biomarkers Product Introduction
2.12.3 Genewiz Neurological Biomarkers Sales, Revenue and Market Share
2.12.3.1 Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.12.3.2 Genewiz Neurological Biomarkers Market Share in Global in 2020
2.13 Proteome Sciences
2.13.1 Business Overview
2.13.1.1 Proteome Sciences Neurological Biomarkers Description
2.13.1.2 Proteome Sciences Neurological Biomarkers Headquarter, Main Business and Finance Overview
2.13.2 Proteome Sciences Neurological Biomarkers Product Introduction
2.13.2.1 Production Bases, Sales Regions and Major Competitors
2.13.2.2 Proteome Sciences Neurological Biomarkers Product Introduction
2.13.3 Proteome Sciences Neurological Biomarkers Sales, Revenue and Market Share
2.13.3.1 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2020-2021)
2.13.3.2 Proteome Sciences Neurological Biomarkers Market Share in Global in 2020
3 Global Neurological Biomarkers Market Competition, by Manufacturer
3.1 Global Neurological Biomarkers Sales and Market Share by Manufacturer (2020-2021)
3.2 Global Neurological Biomarkers Revenue and Market Share by Manufacturer (2020-2021)
3.3 Global Neurological Biomarkers Price by Manufacturer (2020-2021)
3.4 Market Concentration Rate
3.4.1 Top 3 Neurological Biomarkers Manufacturer Market Share
3.4.2 Top 5 Neurological Biomarkers Manufacturer Market Share
3.5 Market Competition Trend
4 Global Neurological Biomarkers Market Analysis by Regions
4.1 Global Neurological Biomarkers Sales, Revenue and Market Share by Regions
4.1.1 Global Neurological Biomarkers Sales by Regions (2012-2021)
4.1.2 Global Neurological Biomarkers Revenue by Regions (2012-2021)
4.2 North America Neurological Biomarkers Sales and Growth (2012-2021)
4.3 Europe Neurological Biomarkers Sales and Growth (2012-2021)
4.4 Asia-Pacific Neurological Biomarkers Sales and Growth (2012-2021)
4.5 South America Neurological Biomarkers Sales and Growth (2012-2021)
4.6 Middle East and Africa Neurological Biomarkers Sales and Growth (2012-2021)
5 North America Neurological Biomarkers by Countries, Type, Application and Manufacturers
5.1 North America Neurological Biomarkers Sales, Revenue and Market Share by Countries
5.1.1 North America Neurological Biomarkers Sales by Countries (2012-2021)
5.1.2 North America Neurological Biomarkers Revenue by Countries (2012-2021)
5.1.3 USA Neurological Biomarkers Sales and Growth (2012-2021)
5.1.4 Canada Neurological Biomarkers Sales and Growth (2012-2021)
5.1.5 Mexico Neurological Biomarkers Sales and Growth (2012-2021)
5.2 North America Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2020-2021)
5.2.1 North America Neurological Biomarkers Sales by Manufacturers (2020-2021)
5.2.2 North America Neurological Biomarkers Revenue by Manufacturers (2020-2021)
5.3 North America Neurological Biomarkers Sales by Type (2012-2021)
5.4 North America Neurological Biomarkers Sales by Application (2012-2021)
6 Europe Neurological Biomarkers by Countries, Type, Application and Manufacturers
6.1 Europe Neurological Biomarkers Sales, Revenue and Market Share by Countries
6.1.1 Europe Neurological Biomarkers Sales by Countries (2012-2021)
6.1.2 Europe Neurological Biomarkers Revenue by Countries (2012-2021)
6.1.3 Germany Neurological Biomarkers Sales and Growth (2012-2021)
6.1.4 UK Neurological Biomarkers Sales and Growth (2012-2021)
6.1.5 France Neurological Biomarkers Sales and Growth (2012-2021)
6.1.6 Russia Neurological Biomarkers Sales and Growth (2012-2021)
6.1.7 Italy Neurological Biomarkers Sales and Growth (2012-2021)
6.2 Europe Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2020-2021)
6.2.1 Europe Neurological Biomarkers Sales by Manufacturers (2020-2021)
6.2.2 Europe Neurological Biomarkers Revenue by Manufacturers (2020-2021)
6.3 Europe Neurological Biomarkers Sales by Type (2012-2021)
6.4 Europe Neurological Biomarkers Sales by Application (2012-2021)
7 Asia-Pacific Neurological Biomarkers by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Neurological Biomarkers Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Neurological Biomarkers Sales by Countries (2012-2021)
7.1.2 Asia-Pacific Neurological Biomarkers Revenue by Countries (2012-2021)
7.1.3 China Neurological Biomarkers Sales and Growth (2012-2021)
7.1.4 Japan Neurological Biomarkers Sales and Growth (2012-2021)
7.1.5 Korea Neurological Biomarkers Sales and Growth (2012-2021)
7.1.6 India Neurological Biomarkers Sales and Growth (2012-2021)
7.1.7 Southeast Asia Neurological Biomarkers Sales and Growth (2012-2021)
7.2 Asia-Pacific Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2020-2021)
7.2.1 Asia-Pacific Neurological Biomarkers Sales by Manufacturers (2020-2021)
7.2.2 Asia-Pacific Neurological Biomarkers Revenue by Manufacturers (2020-2021)
7.3 Asia-Pacific Neurological Biomarkers Sales by Type (2012-2021)
7.4 Asia-Pacific Neurological Biomarkers Sales by Application (2012-2021)
8 South America Neurological Biomarkers by Countries, Type, Application and Manufacturers
8.1 South America Neurological Biomarkers Sales, Revenue and Market Share by Countries
8.1.1 South America Neurological Biomarkers Sales by Countries (2012-2021)
8.1.2 South America Neurological Biomarkers Revenue by Countries (2012-2021)
8.1.3 Brazil Neurological Biomarkers Sales and Growth (2012-2021)
8.1.4 Argentina Neurological Biomarkers Sales and Growth (2012-2021)
8.1.5 Columbia Neurological Biomarkers Sales and Growth (2012-2021)
8.2 South America Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2020-2021)
8.2.1 South America Neurological Biomarkers Sales by Manufacturers (2020-2021)
8.2.2 South America Neurological Biomarkers Revenue by Manufacturers (2020-2021)
8.3 South America Neurological Biomarkers Sales by Type (2012-2021)
8.4 South America Neurological Biomarkers Sales by Application (2012-2021)
9 Middle East and Africa Neurological Biomarkers by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Neurological Biomarkers Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Neurological Biomarkers Sales by Countries (2012-2021)
9.1.2 Middle East and Africa Neurological Biomarkers Revenue by Countries (2012-2021)
9.1.3 Saudi Arabia Neurological Biomarkers Sales and Growth (2012-2021)
9.1.4 UAE Neurological Biomarkers Sales and Growth (2012-2021)
9.1.5 Egypt Neurological Biomarkers Sales and Growth (2012-2021)
9.1.6 Nigeria Neurological Biomarkers Sales and Growth (2012-2021)
9.1.7 South Africa Neurological Biomarkers Sales and Growth (2012-2021)
9.2 Middle East and Africa Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2020-2021)
9.2.1 Middle East and Africa Neurological Biomarkers Sales by Manufacturers (2020-2021)
9.2.2 Middle East and Africa Neurological Biomarkers Revenue by Manufacturers (2020-2021)
9.3 Middle East and Africa Neurological Biomarkers Sales by Type (2012-2021)
9.4 Middle East and Africa Neurological Biomarkers Sales by Application (2012-2021)
10 Global Neurological Biomarkers Market Segment by Type
10.1 Global Neurological Biomarkers Sales, Revenue and Market Share by Type (2012-2021)
10.1.1 Global Neurological Biomarkers Sales and Market Share by Type (2012-2021)
10.1.2 Global Neurological Biomarkers Revenue and Market Share by Type (2012-2021)
10.2 Proteomics Sales Growth and Price
10.2.1 Global Proteomics Sales Growth (2012-2021)
10.2.2 Global Proteomics Price (2012-2021)
10.3 Genomics Sales Growth and Price
10.3.1 Global Genomics Sales Growth (2012-2021)
10.3.2 Global Genomics Price (2012-2021)
10.4 Imaging Sales Growth and Price
10.4.1 Global Imaging Sales Growth (2012-2021)
10.4.2 Global Imaging Price (2012-2021)
10.5 Bioinformatics Sales Growth and Price
10.5.1 Global Bioinformatics Sales Growth (2012-2021)
10.5.2 Global Bioinformatics Price (2012-2021)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2012-2021)
10.6.2 Global Others Price (2012-2021)
11 Global Neurological Biomarkers Market Segment by Application
11.1 Global Neurological Biomarkers Sales Market Share by Application (2012-2021)
11.2 Diagnostics Sales Growth (2012-2021)
11.3 Drug Discovery Sales Growth (2012-2021)
11.4 Personalized Medicine Sales Growth (2012-2021)
11.5 Others Sales Growth (2012-2021)
12 Neurological Biomarkers Market Forecast (2021-2022)
12.1 Global Neurological Biomarkers Sales, Revenue and Growth Rate (2021-2022)
12.2 Neurological Biomarkers Market Forecast by Regions (2021-2022)
12.2.1 North America Neurological Biomarkers Market Forecast (2021-2022)
12.2.2 Europe Neurological Biomarkers Market Forecast (2021-2022)
12.2.3 Asia-Pacific Neurological Biomarkers Market Forecast (2021-2022)
12.2.4 South America Neurological Biomarkers Market Forecast (2021-2022)
12.2.5 Middle East and Africa Neurological Biomarkers Market Forecast (2021-2022)
12.3 Neurological Biomarkers Market Forecast by Type (2021-2022)
12.4 Neurological Biomarkers Market Forecast by Application (2021-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source